XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.85−0.11 (-5.61%)
Close on Nov 16, 2026Market cap $56.40MP/E –Yield –
XBiotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
XBiotech's pe ratio was 1.3× on Jan 29, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 1.3× | +0.2 |
| 2020 | Dec 31, 2020 | 1.1× | – |
See a number that looks wrong?